Omnicell Share Holder Equity 2010-2025 | OMCL
Omnicell share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
| Omnicell Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $1,243 |
| 2023 | $1,189 |
| 2022 | $1,130 |
| 2021 | $1,147 |
| 2020 | $968 |
| 2019 | $845 |
| 2018 | $680 |
| 2017 | $554 |
| 2016 | $432 |
| 2015 | $402 |
| 2014 | $390 |
| 2013 | $349 |
| 2012 | $308 |
| 2011 | $283 |
| 2010 | $265 |
| 2009 | $242 |
| Omnicell Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,257 |
| 2024-12-31 | $1,243 |
| 2024-09-30 | $1,231 |
| 2024-06-30 | $1,203 |
| 2024-03-31 | $1,189 |
| 2023-12-31 | $1,189 |
| 2023-09-30 | $1,187 |
| 2023-06-30 | $1,164 |
| 2023-03-31 | $1,143 |
| 2022-12-31 | $1,130 |
| 2022-09-30 | $1,135 |
| 2022-06-30 | $1,093 |
| 2022-03-31 | $1,075 |
| 2021-12-31 | $1,147 |
| 2021-09-30 | $1,111 |
| 2021-06-30 | $1,053 |
| 2021-03-31 | $1,011 |
| 2020-12-31 | $968 |
| 2020-09-30 | $918 |
| 2020-06-30 | $887 |
| 2020-03-31 | $879 |
| 2019-12-31 | $845 |
| 2019-09-30 | $808 |
| 2019-06-30 | $773 |
| 2019-03-31 | $730 |
| 2018-12-31 | $680 |
| 2018-09-30 | $619 |
| 2018-06-30 | $589 |
| 2018-03-31 | $575 |
| 2017-12-31 | $554 |
| 2017-09-30 | $472 |
| 2017-06-30 | $450 |
| 2017-03-31 | $439 |
| 2016-12-31 | $432 |
| 2016-09-30 | $428 |
| 2016-06-30 | $413 |
| 2016-03-31 | $411 |
| 2015-12-31 | $402 |
| 2015-09-30 | $392 |
| 2015-06-30 | $399 |
| 2015-03-31 | $405 |
| 2014-12-31 | $390 |
| 2014-09-30 | $379 |
| 2014-06-30 | $378 |
| 2014-03-31 | $365 |
| 2013-12-31 | $349 |
| 2013-09-30 | $358 |
| 2013-06-30 | $334 |
| 2013-03-31 | $322 |
| 2012-12-31 | $308 |
| 2012-09-30 | $297 |
| 2012-06-30 | $288 |
| 2012-03-31 | $291 |
| 2011-12-31 | $283 |
| 2011-09-30 | $278 |
| 2011-06-30 | $271 |
| 2011-03-31 | $267 |
| 2010-12-31 | $265 |
| 2010-09-30 | $262 |
| 2010-06-30 | $256 |
| 2010-03-31 | $251 |
| 2009-12-31 | $242 |
| 2009-09-30 | $244 |
| 2009-06-30 | $239 |
| 2009-03-31 | $236 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.322B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.908B | 52.36 |
| Hims & Hers Health (HIMS) | United States | $12.273B | 127.51 |
| Tempus AI (TEM) | United States | $10.774B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.555B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.224B | 66.00 |
| Privia Health (PRVA) | United States | $2.787B | 190.50 |
| Enovis (ENOV) | United States | $1.803B | 10.05 |
| Clover Health Investments (CLOV) | United States | $1.623B | 0.00 |
| Schrodinger (SDGR) | United States | $1.563B | 0.00 |
| Phreesia (PHR) | United States | $1.431B | 0.00 |
| Azenta (AZTA) | United States | $1.236B | 57.45 |
| 10x Genomics (TXG) | United States | $1.006B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.537B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Talkspace (TALK) | United States | $0.472B | 141.00 |
| Claritev (CTEV) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.00 |
| Standard BioTools (LAB) | United States | $0.350B | 0.00 |
| Outset Medical (OM) | United States | $0.318B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.190B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.21 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |